EmeTerm – Removing Nausea from Chemotherapy

Chemotherapy, while instrumental in fighting cancer, often brings along a distressing side effect: nausea and vomiting. For many undergoing treatments, this debilitating symptom adds an extra layer of hardship to an already challenging journey. EmeTerm, a revolutionary anti-nausea wristband designed to relieve nausea and vomiting, can provide comfort to chemotherapy patients and others suffering from motion sickness and morning sickness.

EmeTerm operates by transmitting signals to the central nervous system through targeted electrical stimulation, intercepting and delaying the transmission of nausea signals from the brain to the stomach. This innovative mechanism mitigates the sensation of nausea and prevent vomiting.

Chemotherapy-induced nausea and vomiting can severely impact a patient's quality of life, making everyday activities daunting and burdensome. However, with EmeTerm, patients can find solace in the prospect of alleviating these distressing symptoms. By simply wearing the EmeTerm wristband, individuals undergoing chemotherapy can experience a newfound sense of relief, enabling them to navigate through treatment with greater ease and comfort.

The efficacy of EmeTerm in combating chemotherapy-induced nausea has been substantiated by a study published in the British Journal of Anesthesia (BJA) and numerous testimonials from patients and medical professionals alike. The BJA study reports that EmeTerm provides significant relief of post-operative nausea and vomiting. Many have shared stories of how EmeTerm has transformed their chemotherapy experience, provided much-needed relief, and allowed them to focus on their journey towards recovery. One EmeTerm user expressed, "Chemotherapy brought with it a torrent of nausea that seemed insurmountable. But with EmeTerm, I found a lifeline—a reprieve from the constant discomfort that had overshadowed my treatment. EmeTerm has truly been a game-changer for me."

EmeTerm’s ability to alleviate chemotherapy-induced nausea not only offers tangible relief to patients but also a sense of hope amidst the challenges of cancer treatment. As individuals bravely confront the hurdles of chemotherapy, EmeTerm stands as a steadfast companion, offering support and comfort every step of the way.

 

Reference:

Wearable transcutaneous electrical acupoint stimulation bracelet for prevention of postoperative nausea and vomiting in patients undergoing hysteroscopic surgery: a randomised controlled trial - PubMed

www.emeterm.com

www.watmedical.com

Back to blog